- Home
- CCU vs BHVN Comparison
CCU vs BHVN Comparison
Compare CCU & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- BHVN
- Stock Information
- Founded
- CCU 1850
- BHVN 2013
- Country
- CCU Chile
- BHVN United States
- Employees
- CCU N/A
- BHVN N/A
- Industry
- CCU Beverages (Production/Distribution)
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- BHVN Health Care
- Exchange
- CCU Nasdaq
- BHVN Nasdaq
- Market Cap
- CCU 2.2B
- BHVN 1.8B
- IPO Year
- CCU 1992
- BHVN 2017
- Fundamental
- Price
- CCU $12.51
- BHVN $16.02
- Analyst Decision
- CCU Strong Sell
- BHVN Strong Buy
- Analyst Count
- CCU 1
- BHVN 14
- Target Price
- CCU $10.00
- BHVN $49.23
- AVG Volume (30 Days)
- CCU 141.3K
- BHVN 2.3M
- Earning Date
- CCU 11-05-2025
- BHVN 11-11-2025
- Dividend Yield
- CCU 2.42%
- BHVN N/A
- EPS Growth
- CCU 38.53
- BHVN N/A
- EPS
- CCU 0.44
- BHVN N/A
- Revenue
- CCU $3,254,866,554.00
- BHVN N/A
- Revenue This Year
- CCU $7.11
- BHVN N/A
- Revenue Next Year
- CCU $4.64
- BHVN $2,078.82
- P/E Ratio
- CCU $14.24
- BHVN N/A
- Revenue Growth
- CCU 19.82
- BHVN N/A
- 52 Week Low
- CCU $10.65
- BHVN $12.79
- 52 Week High
- CCU $15.75
- BHVN $54.98
- Technical
- Relative Strength Index (RSI)
- CCU 62.82
- BHVN 52.40
- Support Level
- CCU $11.35
- BHVN $14.83
- Resistance Level
- CCU $11.92
- BHVN $18.08
- Average True Range (ATR)
- CCU 0.29
- BHVN 1.16
- MACD
- CCU 0.09
- BHVN 0.10
- Stochastic Oscillator
- CCU 99.16
- BHVN 43.09
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.